Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Oxidative Stress Signaling Pathways" refers to a complex network of intracellular and intercellular signaling mechanisms that are triggered by imbalances in reactive oxygen species (ROS) and reactive nitrogen species (RNS). These pathways modulate essential cellular processes such as inflammation, apoptosis, metabolism, autophagy, and mitochondrial function. Key elements include antioxidant enzymes (e.g., superoxide dismutase, catalase), regulatory transcription factors (notably Nrf2), and molecular mediators responsive to changes in the redox environment. Abnormal regulation of these pathways contributes to numerous diseases, including cancer, neurodegeneration, cardiovascular disorders, and metabolic diseases. They represent broad therapeutic interest, but as a category, not a discrete therapeutic target.
Mechanism involves scavenging reactive oxygen/nitrogen species, inhibiting ROS production, activating endogenous antioxidant pathways (e.g., Nrf2-ARE activation), modulating mitochondrial function, and regulating redox-sensitive gene expression.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidative Stress Signaling Pathways.